Woodstock Corp’s Elevance Health ELV Stock Holding History

Woodstock Corp’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-440	Closed	-$229K	–	158
2024 Q3	$229K	Sell	440 -16	-4%	-$8.55K	0.02%	154
2024 Q2	$247K	Sell	456 -85	-16%	-$44.9K	0.03%	150
2024 Q1	$281K	Sell	541 -82	-13%	-$40.8K	0.03%	143
2023 Q4	$294K	Sell	623 -17	-3%	-$7.86K	0.03%	143
2023 Q3	$279K	Hold	640	–	–	0.03%	140
2023 Q2	$284K	Sell	640 -6	-0.9%	-$2.77K	0.03%	144
2023 Q1	$297K	Sell	646 -15	-2%	-$7.14K	0.04%	143
2022 Q4	$339K	Sell	661 -8	-1%	-$4.06K	0.05%	134
2022 Q3	$304K	Hold	669	–	–	0.05%	134
2022 Q2	$323K	Sell	669 -44	-6%	-$21.8K	0.04%	135
2022 Q1	$350K	Sell	713 -7	-1%	-$3.2K	0.04%	143
2021 Q4	$334K	Hold	720	–	–	0.04%	159
2021 Q3	$268K	Hold	720	–	–	0.03%	166
2021 Q2	$275K	Sell	720 -25	-3%	-$9.55K	0.03%	166
2021 Q1	$267K	Sell	745 -51	-6%	-$16.4K	0.03%	166
2020 Q4	$256K	Buy	+796	New	+$244K	0.03%	169

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Woodstock Corp's ELV Position: Q4 2024 in Review

Woodstock Corp sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 440 shares — an estimated $229K sold.

Woodstock Corp first reported a position in ELV in Q4 2020 and held it in 16 quarters. The position peaked at $350K in Q1 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Woodstock Corp reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Woodstock Corp sold 440 Elevance Health shares in Q4 2024, an estimated $229K.
Woodstock Corp first reported a position in Elevance Health in Q4 2020 and held it in 16 quarters.
Woodstock Corp's Elevance Health position peaked at $350K in Q1 2022.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Woodstock Corp's 13F filing for Q4 2024, filed 15 Jan 2025.